AIM is one-hundred percent employee owned, founded in 1999.
Vision
To empower our partners, our team, and all others that we serve to make a meaningful difference in the world.
Mission
To advance the goals and visions of our partners through best-in-class management solutions and unparalleled customer service.
AIM is a full-service association management firm based in Reston, Virginia. Our exclusive focus on serving education, scientific, and public health society partners, coupled with our unique business model, allows us to offer a full suite of services delivered by a top-notch team. The purpose of AIM is to help our partners optimize their potential through exceptional partnerships and business practices.
The International Union of Toxicology (IUTOX) achieves its vision by fostering international scientific cooperation for the global acquisition and utilization of knowledge in toxicology for the improvement of human health.
IUTOX is the voice of toxicology on the global stage; the organization seeks to increase the knowledge base of toxicological issues facing humankind and to extend this knowledge to developing societies and nations. Founded in 1980, IUTOX now has 62 affiliated societies representing six continents and over 25,000 toxicologists from industry, academia, and government as members, offering a diverse and challenging perspective on every issue and development relating to the profession.
The leadership of IUTOX is held by the Executive Committee (EC), which changes every three years and is elected by the member-society-appointed delegates. The EC reviews and redefines the IUTOX mission to develop and establish objectives and tasks that will ensure that IUTOX continues to be the voice for toxicology internationally.
Mission
To improve human health through the science and practice of toxicology worldwide.
The Society for Birth Defects Research and Prevention is the premier source for cutting-edge research and authoritative information related to birth defects and other disorders of developmental origin.
Mission
The mission of the Society for Birth Defects Research and Prevention (BDRP) is to understand the cause and pathogenesis of structural and functional birth defects, developmental delays, perinatal death, and other disorders of developmental and reproductive origin in order to prevent their occurrence and improve diagnosis and treatment by promoting multi-disciplinary research and exchange of ideas; communicating information to health professionals, decision-makers, and the public; and providing education and training.
To create a safer and healthier world by advancing the science and increasing the impact of toxicology.
The Society of Toxicology (SOT) is a preeminent scientific organization for professionals involved in toxicology. Founded in 1961, the Society is a global organization with more than 7,000 members from all over the world. The Society is a not-for-profit organization dedicated to the vision of creating a safer and healthier world by advancing the science of toxicology. Toward this vision, SOT strives to increase the scientific impact of the science of toxicology, promote the awareness and recognition of scientific achievements within toxicology, and build for the future of toxicology and is dedicated to increasing the visibility of the organization and its membership as scientific leaders.
The Society’s membership represents the broad spectrum of sciences that toxicology encompasses, ranging from the more mature disciplines of pharmacology, biology, chemistry, microbiology, molecular biology, pathology, pharmacy, and veterinary sciences to the emerging disciplines of genomics, proteomics, and bioinformatics. Members are drawn from academic institutions, industry, government agencies, nonprofit organizations, and private consulting firms and work together to help the organization advance science to enhance and protect human, animal, and environmental health.
Mission
SOT is governed by a 13-person, elected Council and is managed by administrative offices in Reston, Virginia. Because SOT is dedicated to building for the future of toxicology, expanding and deepening membership engagement, and strengthening organizational effectiveness, SOT offers rich and diverse services for members through a vast network of committees and task forces. The Society has 29 Specialty Sections that focus on specific areas in toxicology, 18 Regional Chapters that foster scientific exchanges of information at the national and local levels, and eight Special Interest Groups that are dedicated to increasing the diversity and inclusiveness of the organization.
The vision of the Society of Toxicologic Pathology (STP) is to be an international leader for improvement of human, animal, and environmental health using an interdisciplinary scientific approach based in pathology and toxicology. This vision will be accomplished through four primary goals: recruitment, advocacy, globalization, and education.
Mission
STP was founded in 1971 as a nonprofit association of pathologists and other scientists whose principal aim is the advancement of pathology as it pertains to changes elicited by pharmacological, chemical, or environmental agents and factors that modify these responses. The Society’s 1,250 members in over 20 countries are scientists and professionals who work in academic institutions, government, the pharmaceutical and chemical industry, or contract research organizations or as consultants. They are dedicated to integrating toxicologic pathology into hazard identification, risk assessment, and risk communication regarding human and animal exposure to potentially toxic substances. STP provides expert guidance to legislative and regulatory decision-makers regarding toxicologic pathology data and human or animal health.
The Safety Pharmacology Society is committed to uniting the global safety pharmacology community in the development and safe use of biologically active molecular entities by bridging across disciplines to allow the identification, characterization, and monitoring of potentially undesirable pharmacodynamic activities in nonclinical studies and guiding their translation into clinical trials.
The Safety Pharmacology Society seeks to be a leader in safety pharmacology, providing answers to critical questions that matter to patients, regulators, and scientists.
Mission
The Safety Pharmacology Society is a nonprofit organization that promotes knowledge, development, application, and training in safety pharmacology—a distinct scientific discipline that integrates the best practices of pharmacology, physiology, and toxicology. The objective of safety pharmacology studies is to further the discovery, development, and safe use of biologically active chemical entities by identifying, monitoring, and characterizing potentially undesirable pharmacodynamic activities in nonclinical studies. The Safety Pharmacology Society also supports the human safety of drugs and biologicals by fostering scientific research, education, and dissemination of scientific information through meetings and other scientific interactions.
The American College of Toxicology’s (ACT) vision is to drive strategic growth and visibility through an engaged, diversified membership.
Mission
To educate, lead, and serve professionals in toxicology and related disciplines by promoting the exchange of information and perspectives on applied toxicology and safety assessment.
ACT is a professional organization with a collegial atmosphere. ACT provides educational opportunities through meetings, courses, and webinars and publishes the International Journal of Toxicology. Their primary audience is toxicologists working within industry, pharmaceutical and biotech companies, or government regulatory agencies or as consultants.
The vision of the Toxicology Forum is to be recognized as the leading international toxicology organization that promotes and encourages open dialogue among government agencies, industry, academia, policymakers, and public interest groups concerned with public health issues; such interactions will facilitate sound policy decisions that protect and promote public health.
Mission
The mission of the Toxicology Forum is to encourage open dialogue on human health and environmental issues that drive public concerns, academic involvement, industry action, and regulatory decision-making. This is accomplished through organizing and conducting meetings among government granting and regulatory agencies, the scientific community (academia, government, and industry), and public interest groups. The dialogue at these meetings facilitates the resolution of conflicts, identifies research gaps, drives research agendas, and promotes sound regulatory and policy decision-making. The proceedings from meetings of the Toxicology Forum are made publicly available. The Toxicology Forum always strives to provide balanced programs, does not advocate for any particular scientific or policy position discussed during their meetings, and does not attempt to reach consensus from the discussions and presentations. The Toxicology Forum encourages participation in their forums from scientific and policy experts in government, industry, academia, and consumer interest groups, and they provide the necessary infrastructure support to accomplish this mission.
International Federation of Clinical Neurophysiology
AIM Partner Since 2020
Vision
To improve healthcare by understanding the nervous system and optimizing the diagnosis and treatment of its disorders through clinical neurophysiology.
Mission
To promote best practices in clinical neurophysiology through education and research throughout the world.
The Collaborative Community on Ophthalmic Imaging has set out to clarify challenges, best practices, strategies and standards while advancing innovation in the ophthalmic imaging space. The stakeholders involved are seeking to develop solutions to refine the diagnosis, management and treatment of patients with eye diseases, along with other medical conditions.
AIM is one-hundred percent employee owned, founded in 1999.
Association Innovation and Management, Inc.
Vision
To empower our partners, our team, and all others that we serve to make a meaningful difference in the world.
Mission
To advance the goals and visions of our partners through best-in-class management solutions and unparalleled customer service.
AIM is a full-service association management firm based in Reston, Virginia. Our exclusive focus on serving education, scientific, and public health society partners, coupled with our unique business model, allows us to offer a full suite of services delivered by a top-notch team. The purpose of AIM is to help our partners optimize their potential through exceptional partnerships and business practices.
The International Union of Toxicology (IUTOX) achieves its vision by fostering international scientific cooperation for the global acquisition and utilization of knowledge in toxicology for the improvement of human health.
IUTOX is the voice of toxicology on the global stage; the organization seeks to increase the knowledge base of toxicological issues facing humankind and to extend this knowledge to developing societies and nations. Founded in 1980, IUTOX now has 62 affiliated societies representing six continents and over 25,000 toxicologists from industry, academia, and government as members, offering a diverse and challenging perspective on every issue and development relating to the profession.
The leadership of IUTOX is held by the Executive Committee (EC), which changes every three years and is elected by the member-society-appointed delegates. The EC reviews and redefines the IUTOX mission to develop and establish objectives and tasks that will ensure that IUTOX continues to be the voice for toxicology internationally.
Mission
Improve human health through the science and practice of toxicology worldwide.
To create a safer and healthier world by advancing the science and increasing the impact of toxicology.
The Society of Toxicology (SOT) is a preeminent scientific organization for professionals involved in toxicology. Founded in 1961, the Society is a global organization with more than 7,000 members from all over the world. The Society is a not-for-profit organization dedicated to the vision of creating a safer and healthier world by advancing the science of toxicology. Toward this vision, SOT strives to increase the scientific impact of the science of toxicology, promote the awareness and recognition of scientific achievements within toxicology, and build for the future of toxicology and is dedicated to increasing the visibility of the organization and its membership as scientific leaders.
The Society’s membership represents the broad spectrum of sciences that toxicology encompasses, ranging from the more mature disciplines of pharmacology, biology, chemistry, microbiology, molecular biology, pathology, pharmacy, and veterinary sciences to the emerging disciplines of genomics, proteomics, and bioinformatics. Members are drawn from academic institutions, industry, government agencies, nonprofit organizations, and private consulting firms and work together to help the organization advance science to enhance and protect human, animal, and environmental health.
Mission
SOT is governed by a 13-person, elected Council and is managed by administrative offices in Reston, Virginia. Because SOT is dedicated to building for the future of toxicology, expanding and deepening membership engagement, and strengthening organizational effectiveness, SOT offers rich and diverse services for members through a vast network of committees and task forces. The Society has 29 Specialty Sections that focus on specific areas in toxicology, 18 Regional Chapters that foster scientific exchanges of information at the national and local levels, and eight Special Interest Groups that are dedicated to increasing the diversity and inclusiveness of the organization.
The Society for Birth Defects Research and Prevention is the premier source for cutting-edge research and authoritative information related to birth defects and other disorders of developmental origin.
Mission
The mission of the Society for Birth Defects Research and Prevention (BDRP) is to understand the cause and pathogenesis of structural and functional birth defects, developmental delays, perinatal death, and other disorders of developmental and reproductive origin in order to prevent their occurrence and improve diagnosis and treatment by promoting multi-disciplinary research and exchange of ideas; communicating information to health professionals, decision-makers, and the public; and providing education and training.
The vision of the Society of Toxicologic Pathology (STP) is to be an international leader for improvement of human, animal, and environmental health using an interdisciplinary scientific approach based in pathology and toxicology. This vision will be accomplished through four primary goals: recruitment, advocacy, globalization, and education.
Mission
STP was founded in 1971 as a nonprofit association of pathologists and other scientists whose principal aim is the advancement of pathology as it pertains to changes elicited by pharmacological, chemical, or environmental agents and factors that modify these responses. The Society’s 1,250 members in over 20 countries are scientists and professionals who work in academic institutions, government, the pharmaceutical and chemical industry, or contract research organizations or as consultants. They are dedicated to integrating toxicologic pathology into hazard identification, risk assessment, and risk communication regarding human and animal exposure to potentially toxic substances. STP provides expert guidance to legislative and regulatory decision-makers regarding toxicologic pathology data and human or animal health.
The Safety Pharmacology Society is committed to uniting the global safety pharmacology community in the development and safe use of biologically active molecular entities by bridging across disciplines to allow the identification, characterization, and monitoring of potentially undesirable pharmacodynamic activities in nonclinical studies and guiding their translation into clinical trials.
The Safety Pharmacology Society seeks to be a leader in safety pharmacology, providing answers to critical questions that matter to patients, regulators, and scientists.
Mission
The Safety Pharmacology Society is a nonprofit organization that promotes knowledge, development, application, and training in safety pharmacology—a distinct scientific discipline that integrates the best practices of pharmacology, physiology, and toxicology. The objective of safety pharmacology studies is to further the discovery, development, and safe use of biologically active chemical entities by identifying, monitoring, and characterizing potentially undesirable pharmacodynamic activities in nonclinical studies. The Safety Pharmacology Society also supports the human safety of drugs and biologicals by fostering scientific research, education, and dissemination of scientific information through meetings and other scientific interactions.
The American College of Toxicology’s (ACT) vision is to drive strategic growth and visibility through an engaged, diversified membership.
Mission
To educate, lead, and serve professionals in toxicology and related disciplines by promoting the exchange of information and perspectives on applied toxicology and safety assessment.
ACT is a professional organization with a collegial atmosphere. ACT provides educational opportunities through meetings, courses, and webinars and publishes the International Journal of Toxicology. Their primary audience is toxicologists working within industry, pharmaceutical and biotech companies, or government regulatory agencies or as consultants.
The vision of the Toxicology Forum is to be recognized as the leading international toxicology organization that promotes and encourages open dialogue among government agencies, industry, academia, policymakers, and public interest groups concerned with public health issues; such interactions will facilitate sound policy decisions that protect and promote public health.
Mission
The mission of the Toxicology Forum is to encourage open dialogue on human health and environmental issues that drive public concerns, academic involvement, industry action, and regulatory decision-making. This is accomplished through organizing and conducting meetings among government granting and regulatory agencies, the scientific community (academia, government, and industry), and public interest groups. The dialogue at these meetings facilitates the resolution of conflicts, identifies research gaps, drives research agendas, and promotes sound regulatory and policy decision-making. The proceedings from meetings of the Toxicology Forum are made publicly available. The Toxicology Forum always strives to provide balanced programs, does not advocate for any particular scientific or policy position discussed during their meetings, and does not attempt to reach consensus from the discussions and presentations. The Toxicology Forum encourages participation in their forums from scientific and policy experts in government, industry, academia, and consumer interest groups, and they provide the necessary infrastructure support to accomplish this mission.
International Federation of Clinical Neurophysiology
AIM Partner since 2020
International Federation of Clinical Neurophysiology
Vision
To improve healthcare by understanding the nervous system and optimizing the diagnosis and treatment of its disorders through clinical neurophysiology.
Mission
To promote best practices in clinical neurophysiology through education and research throughout the world.
The Collaborative Community on Ophthalmic Imaging has set out to clarify challenges, best practices, strategies and standards while advancing innovation in the ophthalmic imaging space. The stakeholders involved are seeking to develop solutions to refine the diagnosis, management and treatment of patients with eye diseases, along with other medical conditions.
